Cumberland Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cumberland Pharmaceuticals Inc. (CPIX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents17.9618.3219.7627.0424.7528.2136.23
Cash & Short-Term Investments17.9618.3219.7627.0424.7528.2136.23
Accounts Receivable11.709.7613.166.8812.387.867.84
Inventory4.004.619.868.4310.6415.6012.08
Other Current Assets2.793.033.083.342.202.460.00
Total Current Assets36.4535.7145.8745.6949.9750.1659.12
Non-Current Assets
Property, Plant & Equipment (Net)6.457.045.501.472.602.960.77
Goodwill0.910.910.910.880.880.000.00
Intangible Assets17.9722.6130.5923.9528.120.000.00
Other Non-Current Assets13.7915.5010.0512.4714.893.3018.28
Total Non-Current Assets39.1346.0647.0538.7746.4938.0853.58
Total Assets75.5881.7892.9384.4696.46104.55112.69
Current Liabilities
Accounts Payable13.9114.0410.8218.3113.4021.0814.90
Short-Term Debt5.460.000.000.000.000.000.00
Accrued Liabilities2.079.1610.805.045.360.000.00
Other Current Liabilities12.254.4317.591.345.892.1511.64
Total Current Liabilities31.6227.9828.5819.2825.6724.1527.80
Non-Current Liabilities
Long-Term Debt15.1212.7820.7915.0915.0020.5820.00
Other Non-Current Liabilities6.306.457.597.497.868.749.32
Total Non-Current Liabilities21.4224.5328.3722.5823.9229.3129.32
Total Liabilities53.0452.5256.9541.8649.5953.4657.12
Stockholders' Equity
Common Stock46.8247.0947.4748.4549.120.000.00
Retained Earnings-23.97-17.49-11.21-5.64-2.131.214.75
Minority Interest-0.31-0.34-0.29-0.21-0.12-0.04-0.27
Shares Outstanding13.9514.1214.3714.740.000.000.00
Total Stockholders' Equity22.8529.2635.9742.6046.8751.0955.57
Total Liabilities & Equity75.5881.7892.9384.4696.46104.55112.69